The authors concluded that the current peer-reviewed evidence seemed inadequate to generally recommend incorporation of moderate-to-high intensity resistance training into exercise-based rehabilitation programmes for patients with chronic heart failure. The authors' conclusion is appropriately cautious and represents the evidence presented, but its reliability is unclear given the small number of included trials, their small sample sizes and poor quality.
Study selection
Eligible for inclusion in the review were randomised and non-randomised controlled trials that compared supervised moderate-to-high resistance training to placebo, another exercise modality, resistance training combined with another exercise modality, or a usual care, in patients with chronic heart failure. Trials with nutrition and/or hormone modulation or that had resistance-training programmes using cycle ergometers, whole-body vibration or single leg training were excluded form the review. Details of the review methods were reported in a separate online appendix (see URL for Additional Data).
Moderate to high intensity resistance exercise was defined, using the American Heart Association definition, as an exercise modality in which skeletal muscle groups of upper and/or lower limbs are trained by repetitive lifting (maximum two to four series of 15 repetitions) of relatively heavy weights (over 60% or increasing to over 60% of the one-repetition maximum). Additionally, resistance training had to be performed in a rhythmical manner preferably at moderate to slow controlled speed.
Outcome measures, which were not specified a priori, included indices of cardiovascular function, skeletal muscle function, body composition, functional exercise capacity, peak exercise capacity and disease-specific quality of life. Adverse events were also reported in the review.
Trials included in the review compared: resistance training versus usual care, low intensity stretching, endurance training plus resistance training, and endurance training versus usual care; resistance training plus endurance training versus endurance training only (where reported). Training frequencies were twice per week for 10 to 20 weeks, or three times per week for eight to 23 weeks. The mean age of participants ranged from 50 to 77 years. Most trials were of men only and excluded patients with comorbidities such as diabetes. Included patients had a New York Heart Association (NYHA) classification of I, II or III (where reported).
Results of the review
Nine trials were included in the review (seven RCTs and two non-RCTs; 260 participants; sample sizes ranged from 15 to 60 patients). One trial scored 8 on the Delphi list and four scored 3 or below. The average score was 4.3 points, which was regarded as poor quality. Where reported, mean compliance rate was from 75% to 100%.
Resistance training (four trials: three RCTs, one non-RCT): There was no statistically significant difference between resistance training and usual care or low intensity stretching in left ventricular contractile function or on myocardial deterioration. Whilst some trials showed a significant difference in favour of resistance training for mean change in peripheral muscle strength and endurance, submaximal exercise capacity, peak aerobic capacity and disease specific quality of life, others did not.
Resistance training plus endurance training (five trials: four RCTs, one non-RCT): There were no statistically significant difference between resistance training in combination with endurance training versus endurance training alone on left ventricular contractile function, or on myocardial deterioration, cardiac function, NYHA classification, disease-specific quality of life, body composition, peripheral muscle strength and peak aerobic capacity.
Adverse events: One trial reported adverse events as a pre-defined secondary outcome, and reported no adverse events. Nine trials did not pre-define adverse events as an outcome measure. However, two trials reported adverse events in the resistance training group (hospitalisation due to severe asthma attack in one participant; assigned one week rest due to low back pain that could not be related to intervention in one participant); five of these trias reported a serious adverse event in the endurance training group (a period of severe hypotension in one patient; withdrawal due to worsening chronic heart failure in one patient; unable to make time commitment to study in two patients; and drop-out due to hospitalisation for rapid rate atrial fibrillation in one patient). In the combined resistance and endurance training group, two patients dropped out due to lymphoma and ischialgia in one trial.
